BBCIC Announces Major Milestone; Prepares for Comparative Effectiveness and Safety Studies of Biosimilars Coming to Market in 2017

Press Release: The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) this month reached a significant new phase of operation, posting research protocols that will lay the groundwork for comparative effectiveness and safety studies of biosimilars currently available or projected to enter the market next year.
Biosimilars

AMCP Foundation’s Symposium Gathers Diverse Stakeholders to Address Issues of Opioid Misuse and Abuse

Press Release: Improvements to opioid prescribing, increasing the use of naloxone to reverse opioid overdose and expanding the use of medication-assisted treatment (MAT) for opioid-use disorders were among the many suggestions to come out of the Academy of Managed Care Pharmacy (AMCP) Foundation 6th Annual Research Symposium, “Balancing Access and Use of Opioid Therapy.”
Opioid Stewardship, Substance Use Disorder , Managed Care Practice Issues

Stakeholders Recommend Manufacturers Share Off-Label Information on Medications Awaiting FDA Approval with Decision Makers

Press Release: Biopharmaceutical companies and health care decision makers would be able to more easily communicate information on products awaiting Food and Drug Administration (FDA) approval, under recommendations developed at an Academy of Managed Care Pharmacy (AMCP) partnership forum this week.
Formulary & Utilization Management, Expedited Approval